Leaflet manual of external beam radiation therapy for hepatocellular carcinoma: a review of the indications, evidences, and clinical trials

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• BeasleyRPHwangLYLinCCChienCSHepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in TaiwanLancet198128256112911336118576
   PubMed Web of Science ®Google Scholar
• SakumaKSaitohNKasaiMRelative risks of death due to liver disease among Japanese male adults having various statuses for hepatitis B s and e antigen/antibody in serum: a prospective studyHepatology198886164216463192178
   PubMed Web of Science ®Google Scholar
• LlovetJMBruCBruixJPrognosis of hepatocellular carcinoma: the BCLC staging classificationSemin Liver Dis199919332933810518312
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the LiverEuropean Organisation for Research and Treatment of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol201256490894322424438
   PubMed Web of Science ®Google Scholar
• ChaHParkHCYuJIClinical practice patterns of radiotherapy in patients with hepatocellular carcinoma: a Korean Radiation Oncology Group Study (KROG 14-07)Cancer Res Treat2017491616927338036
   PubMed Web of Science ®Google Scholar
• ChengSChenMCaiJChinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 editionOncotarget2017858867887627780939
   PubMedGoogle Scholar
• RimCHSeongJApplication of radiotherapy for hepatocellular carcinoma in current clinical practice guidelinesRadiat Oncol J201634316016727730805
   PubMedGoogle Scholar
• National Comprehensive Cancer Network (NCCN)®NCCN Guidelines version 1. 2018, hepatobiliary cancers Available from: https://www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdfAccessed April 2, 2018
   Google Scholar
• EmamiBLymanJBrownATolerance of normal tissue to therapeutic irradiationInt J Radiat Oncol Biol Phys19912111091222032882
   PubMed Web of Science ®Google Scholar
• FengMBen-JosefERadiation therapy for hepatocellular carcinomaSemin Radiat Oncol201121427127721939856
   PubMed Web of Science ®Google Scholar
• Ben-JosefENormolleDEnsmingerWDPhase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignanciesJ Clin Oncol200523248739874716314634
   PubMed Web of Science ®Google Scholar
• DawsonLAMcGinnCJNormolleDEscalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignanciesJ Clin Oncol200018112210211810829040
   PubMed Web of Science ®Google Scholar
• SeongJKeumKCHanKHCombined transcatheter arterial chemoembolization and local radiotherapy of unresectable hepatocellular carcinomaInt J Radiat Oncol Biol Phys199943239339710030267
   PubMed Web of Science ®Google Scholar
• KimTHParkJWKimYJSimultaneous integrated boost-intensity modulated radiation therapy for inoperable hepatocellular carcinomaStrahlenther Onkol20141901088289024638270
   PubMed Web of Science ®Google Scholar
• CitrinDERecent developments in radiotherapyN Engl J Med20173772222002201
   PubMed Web of Science ®Google Scholar
• GuckenbergerMAndratschkeNAlheitHDeutschen Gesellschaft für Radioonkologie (DEGRO)Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancerStrahlenther Onkol20141901263324052011
   PubMed Web of Science ®Google Scholar
• SanukiNTakedaAKuniedaERole of stereotactic body radiation therapy for hepatocellular carcinomaWorld J Gastroenterol201420123100311124696597
   PubMed Web of Science ®Google Scholar
• LlovetJMBustamanteJCastellsANatural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trialsHepatology199929162679862851
   PubMed Web of Science ®Google Scholar
• NagasueNYukayaHHamadaTHiroseSKanashimaRInokuchiKThe natural history of hepatocellular carcinoma. A study of 100 untreated casesCancer1984547146114656205743
   PubMed Web of Science ®Google Scholar
• LlovetJMRicciSMazzaferroVSHARP Investigators Study GroupSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839018650514
   PubMed Web of Science ®Google Scholar
• ChengALKangYKChenZEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialLancet Oncol2009101253419095497
   PubMed Web of Science ®Google Scholar
• JeongSWJangJYShimKYPractical effect of sorafenib monotherapy on advanced hepatocellular carcinoma and portal vein tumor thrombosisGut Liver20137669670324312711
   PubMed Web of Science ®Google Scholar
• BezjakAPaulusRGasparLPrimary study endpoint analysis for NRG oncology/RTOG 0813 trial of stereotactic body radiation therapy (SBRT) for centrally located non-small cell lung cancer (NSCLC)Int J Radiat Oncol Biol Phys201694156
   Web of Science ®Google Scholar
• National Comprehensive Cancer Network (NCCN)®Principle of radiation therapy. NCCN guidelines version 4.2018, non-small cell lung cancer Available from: https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdfAssessed April 2, 2018
   Google Scholar
• VideticGMHuCSinghAKA randomized phase 2 study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer: NRG oncology RTOG 0915 (NCCTG N0927)Int J Radiat Oncol Biol Phys201593475776426530743
   PubMed Web of Science ®Google Scholar
• NakazawaTHidakaHShibuyaAOverall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysisBMC Gastroenterol2014148424886354
   PubMed Web of Science ®Google Scholar
• RimCHKimCYYangDSYoonWSComparison of radiation therapy modalities for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis and systematic reviewRadiother Oncol Epub2017129
   Web of Science ®Google Scholar
• LeeIJChungJWKimHCExtrahepatic collateral artery supply to the tumor thrombi of hepatocellular carcinoma invading inferior vena cava: the prevalence and determinant factorsJ Vasc Interv Radiol2009201222919026566
   PubMed Web of Science ®Google Scholar
• KooJEKimJHLimYSCombination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombusInt J Radiat Oncol Biol Phys201078118018719926229
   PubMed Web of Science ®Google Scholar
• RimCHKimCYYangDSYoonWSExternal beam radiation therapy to hepatocellular carcinoma involving inferior vena cava and/or right atrium: a meta-analysis and systemic reviewRadiother Oncol Epub2018329
   Web of Science ®Google Scholar
• RyderSDRizziPMMetivierEKaraniJWilliamsRChemoembolisation with lipiodol and doxorubicin: applicability in British patients with hepatocellular carcinomaGut19963811251288566839
   PubMed Web of Science ®Google Scholar
• EbiedOMFederleMPCarrBIEvaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinomaCancer20039741042105012569604
   PubMed Web of Science ®Google Scholar
• LeeIJSeongJRadiosensitizers in hepatocellular carcinomaSemin Radiat Oncol201121430331121939860
   PubMed Web of Science ®Google Scholar
• HuoYREslickGDTranscatheter arterial chemoembolization plus radiotherapy compared with chemoembolization alone for hepatocellular carcinoma: a systematic review and meta-analysisJAMA Oncol20151675676526182200
   PubMed Web of Science ®Google Scholar
• SumieSYamashitaFAndoEInterventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolizationAJR Am J Roentgenol200318151327133414573429
   PubMed Web of Science ®Google Scholar
• LeeHSChoiGHChoiJSSurgical resection after down-staging of locally advanced hepatocellular carcinoma by localized concurrent chemoradiotherapyAnn Surg Oncol201421113646365324916746
   PubMed Web of Science ®Google Scholar
• ByunHKKimHJImYRSeongJLiver-directed concurrent chemo-radiotherapy with high-dose radiation is effective in Barcelona Clinic Liver Cancer stage C hepatocellular carcinomaPoster presented at: The 35th Annual Meeting of Korean Society for Radiation OncologyOctober 13; 2017Seoul, KoreaS133
   Google Scholar
• GuckenbergerMSweeneyRAWilbertJImage-guided radiotherapy for liver cancer using respiratory-correlated computed tomography and cone-beam computed tomographyInt J Radiat Oncol Biol Phys200871129730418406894
   PubMed Web of Science ®Google Scholar
• GuckenbergerMMeyerJWilbertJIntra-fractional uncertainties in cone-beam CT based image-guided radiotherapy (IGRT) of pulmonary tumorsRadiother Oncol2007831576417306394
   PubMed Web of Science ®Google Scholar
• KuboHDHillBCRespiration gated radiotherapy treatment: a technical studyPhys Med Biol199641183918685260
   PubMed Web of Science ®Google Scholar
• BujoldAMasseyCAKimJJSequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinomaJ Clin Oncol201331131631163923547075
   PubMed Web of Science ®Google Scholar
• LasleyFDManninaEMJohnsonCSTreatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1–2 trial of stereotactic body radiation therapyPract Radiat Oncol201555e443e44925899219
   PubMedGoogle Scholar
• ScorsettiMComitoTCampisiMThe challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT)Int J Radiat Oncol Biol Phys2014901S376S377
   Web of Science ®Google Scholar
• KangJKKimMSChoCKStereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolizationCancer2012118215424543122570179
   PubMed Web of Science ®Google Scholar
• QiWXFuSZhangQGuoXMCharged particle therapy versus photon therapy for patients with hepatocellular carcinoma: a systematic review and meta-analysisRadiother Oncol2015114328929525497556
   PubMed Web of Science ®Google Scholar
• MengMBCuiYLLuYTranscatheter arterial chemoembolization in combination with radiotherapy for unresectable hepatocellular carcinoma: a systematic review and meta-analysisRadiother Oncol200992218419419042048
   PubMed Web of Science ®Google Scholar
• YoonSMSorafenib versus transarterial chemoembolization plus external beam radiotherapy in patients with hepatocellular carcinoma with major vascular invasion (START): a randomized phase 2 trialWashington, DCThe Liver Meeting2017 Available from: http://liverlearning.aasld.org/aasld/2017/thelivermeeting/194907/sang.min.yoon.sorafenib.versus.transarterial.chemoembolization.plus.external.htmlAccessed November 20, 2017
   Google Scholar
• HeimbachJKKulikLMFinnRSAASLD guidelines for the treatment of hepatocellular carcinomaHepatology201867135838028130846
   PubMed Web of Science ®Google Scholar
• ParkHCYuJIChengJCConsensus for radiotherapy in hepatocellular carcinoma from the 5th Asia-Pacific Primary Liver Cancer Expert Meeting (APPLE 2014): current practice and future clinical trialsLiver Cancer20165316217427493892
   PubMed Web of Science ®Google Scholar
• Korean Liver Cancer Study Group (KLCSG)National Cancer Center, Korea (NCC)2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinomaKorean J Radiol201516346552225995680
   PubMed Web of Science ®Google Scholar